Urology

Results from the EMPOWUR extension study presented at the virtual International Continence Society Annual Meeting showed that vibegron, a beta-3 adrenergic agonist taken daily, could help treat patients with overactive bladder.

Bacillus Calmette-Guérin, or BCG, is highly effective at treating and preventing recurrence of early-stage bladder cancer.